November 20, 2017
Authored and Edited by Adriana L. Burgy; Charles E. Van Horn
On November 14, 2017, the USPTO issued and published the final rule, “Setting and Adjusting Patent Fees during Fiscal Year 2017.” The final rule set or adjusted certain patent fees, as provided by the Leahy-Smith America Invents Act (AIA). This rulemaking is the second iteration of patent fee rulemaking by the USPTO under AIA; the first was January 2013. This rule is effective on January 16, 2018, for patent fees paid on or after January 16, 2018.
The USPTO published a table summarizing the new or adjusted fees, which can be found here. Below summarizes the notable changes in fees.
|
Fee |
Current Large |
Final Rule Large |
Percentage Change |
|
Utility Patent Application Fees |
|||
|
Utility Filing Fee |
$280 |
$300 |
7% |
|
Utility Search Fee |
$600 |
$660 |
10% |
|
Utility Examination Fee |
$720 |
$760 |
6% |
|
Utility Issue Fee |
|||
|
Utility Issue Fee |
$960 |
$1000 |
4% |
|
Provisional Application Filing |
|||
|
Provisional Application Filing Fee |
$260 |
$280 |
8% |
|
Design Patent Application Fees |
|||
|
Design Filing Fee |
$180 |
$200 |
11% |
|
Design Search Fee |
$120 |
$160 |
33% |
|
Design Examination Fee |
$460 |
$600 |
30% |
|
Design Issue Fee |
|||
|
Design Issue Fee |
$560 |
$700 |
25% |
|
Plant Patent Application Filing Fees |
|||
|
Plant Filing Fee |
$180 |
$200 |
11% |
|
Plant Search Fee |
$380 |
$420 |
11% |
|
Plant Examination Fee |
$580 |
$620 |
7% |
|
Plant Issue Fee |
|||
|
Plant Issue Fee |
$760 |
$800 |
5% |
|
Excess Claim Fees |
|||
|
Each Independent Claim in Excess of Three |
$420 |
$460 |
10% |
|
Each Claim in Excess of 20 |
$80 |
$100 |
25% |
|
Multiple Dependent Claims |
$780 |
%820 |
5% |
|
Information Disclosure Statement (IDS) |
|||
|
Submission of an IDS after First Action on the Merits, before Notice of Allowance |
$180 |
$240 |
33% |
|
Request for Continued Examination (RCE) |
|||
|
RCE - 1st Request |
$1,200 |
$1,300 |
8% |
|
RCE - 2nd and Subsequent Request |
$1,700 |
$1,900 |
12% |
|
Appeal Fees |
|||
|
Notice of Appeal |
$800 |
$800 |
no change |
|
Forwarding an Appeal Brief in an Application or Ex Parte Reexamination Proceeding to the Board |
$2,000 |
$2,240 |
12% |
|
NEW Patent Fees |
|||
|
Ex Parte Reexamination (§ 1.510(a)) Streamlined |
- - |
$6,000 (non-streamlined remains at $12,000) |
- - |
|
Hague International Design Application |
- - |
$120 |
- - |
|
Submission of sequence listing of 300 MB to 800 MB |
- - |
$1,000 |
- - |
|
Submission of sequence listings of more than 800 MB |
- - |
$10,000 |
- - |
|
Late Filing of Sequence Listing |
- - |
$300 |
- - |
Copyright © 2017 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
At the PTAB Blog
Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a
§ 325(d) EPR Denial
May 28, 2026
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Webinar
Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement
May 18, 2026
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.